Contributing Member of the Technology, Media & Telecom Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Any Surprise Any Place: www.asap.co.in: Plan Surprises

May 18, 2010

Analysis of:New concepts in Gifting | asap.co.in

Any surprise any place or ASAP packages surprises and personalized gifts on your behalf. If you have not surprised your wife, parents, boss, girl friends, sons, daughters, or even a colleague... just call us and we will do anything you want.

Workforce Development in the the Indian Automotive Industry

September 10, 2009

Analysis of:What will it take for the Indian auto industry to become a global leader? | geetikasharmaacademician

India as the Automotive Industry hub

Finishing School@ India

September 8, 2009

Analysis of:Human Asset Development for India | geetikasharmacorporatetrainer

Soft Skill Training & vocational and finishing school courses

Pharmaceutical Outsourcing and the Importance of 24 Hour

September 7, 2009

Analysis of:Outsourcing Clinical Trials to India & the Cost of Developing a New Drug. | msnoopursinghcrapanaceabiotech

India Becoming Favored Destination for Clinical Trials.

Merck & Co., Inc the leader in therapeutic segment

September 7, 2009

Analysis of:Analysis of Merck | mit.edu

The King of Pharma

KG Basin Gas is not the only solution

September 6, 2009

Analysis of:You and I can combat gas prices! : Let us give a try by controlling Inventory | authorgeetikasharma

The Golden way to save fuel

Future Markets in Commodities is a major worry for Govt of India

September 6, 2009

Analysis of:Price Risk Management for Commodities | 3rdinternationalconference

Govt of India could not achieve procurement due to Hedging of Commodities

Intellectual Property Right for Pharmaceutical Company

September 5, 2009

Analysis of:Trade mark Protection for Pharmaceutical Company in India | neetaramsinghani

IPR the need of the hour

High Tech Engineering for India,s Defence Need

September 5, 2009

Analysis of:CREATION OF A JOINT VENTURE BETWEEN SOGECLAIR AND VECTRA GROUP IN INDIA | 129927_88_5s38_sogeclair-comm-en.pdf

SOGECLAIR is a high-tech engineering company organised in two business units,"Engineering & Consulting" and "Simulation", at the service of three distinct markets:"Aeronautics & Air Traffic" - "Automobile & Rail" - " Defence & Industry".

Cleanchit to Nimesulide

September 5, 2009

Analysis of:The CHMP/EMEA has confirmed that the benefit/risk profile of Nimesulide is positive | nime_emea2007.pdf

NIMESULIDE is one of the most used non-steroidal anti-inflammatory drugs in the EU.Present on the market since 1985, nimesulide-containing products are currentlyavailable in approximately 50 countries. To date, 500 million courses of treatmenthave been made in 22 years of marketing

Nimesulide should be banned

September 5, 2009

Analysis of:SUSPENSION OF NIMESULIDE FROM THE IRISH MARKET, PENDING EU | 1pressrelease15may2007.pdf

Nimesulide a wonder drug

Achieiving Effective Pain Management

September 5, 2009

Analysis of:HELSINN HEALTHCARE PRESENTS NEW DATA ON ORINAL NIMESULIDE AT THE WORLD INSTITUTE OF PAIN CONGRESS | helsinnoutcomewip2007-07-10-18.pdf

“Efficacy and tolerability of nimesulide for thetreatment of migraine attacks

Quality Clinical Research in India

September 5, 2009

Analysis of:PAREXEL Pharmaceutical R&D | pxl_cooper-03-03-2009

India is R&D hub for pharmaceuticals